Source:http://linkedlifedata.com/resource/pubmed/id/16807582
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1236
|
| pubmed:dateCreated |
2006-6-29
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1175-8716
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
119
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
U2040
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:16807582-Diabetes Mellitus,
pubmed-meshheading:16807582-Drug Approval,
pubmed-meshheading:16807582-Humans,
pubmed-meshheading:16807582-Hypoglycemic Agents,
pubmed-meshheading:16807582-Insulin,
pubmed-meshheading:16807582-Insulin, Long-Acting,
pubmed-meshheading:16807582-National Health Programs,
pubmed-meshheading:16807582-New Zealand
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
|
| pubmed:publicationType |
Letter,
Comment
|